Stock Analysts

Bayer’s Stivarga Cleared in the EU

The European Commission recently approved Bayer ’s ( BAYRY ) Stivarga (regorafenib) for the treatment of adults suffering from metastatic colorectal cancer (mCRC) whose disease has progressed even after treatment with standard drugs. The EU approval of Stivarga did not come as a surprise as, in Jun 2013, the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) provided a positive opinion on the approval of Stivarga in the mCRC indication. The European approval of Stivarga was based on positive results from Bayer’s phase III CORRECT (Colorectal cancer treated with regorafenib or placebo after failure of standard therapy) study […]

Stock Analysts

MWI Vet to Take Over Competitor

In a concerted effort to strengthen its business in the domestic market, MWI Veterinary Supply Inc. ( MWIV ) inked a definitive agreement to acquire all the assets of U.S.-based key competitor IVESCO Holdings for $67.5 million. The company expects to complete the acquisition by the first quarter of fiscal 2014 (ending Dec 31, 2013) […]

Stock Analysts

Goodyear Launches New Racing Tire

Goodyear Tire & Rubber Company ( GT ) utilized its street technology in the racing field to create the newly-designed Eagle race tire. These tires will be used in vehicles participating in the NASCAR Sprint Cup and Nationwide Series races at Atlanta Motor Speedway. […]

Stock Analysts

Swissmedic Negative on Apricus’ Vitaros

Apricus Biosciences, Inc. ( APRI ) recently received a negative opinion from Swissmedic, the Agency for Therapeutic Products in Switzerland. Swissmedic is not in favor of granting marketing approval to Vitaros, indicated for erectile dysfunction, based on some quality related issues. […]

Stock Analysts

Aeropostale Shares Lose Sheen

Shares of Aeropostale, Inc. ( ARO ) tumbled to touch a 52-week low of $8.29 on Thursday, Aug 29, and eventually closed trade at $8.36. Looking at the year-to-date performance, the stock has disappointed too, as it has plunged 33.7%. […]

Stock Analysts

Playing Defense

Military conflict is in the air because of chemical weapons use in the Syrian civil war. The geopolitical landscape in the Middle East is tense beyond Syria given social turmoil in Egypt, social unrest in Libya, and Iran’s nuclear development. Geopolitical instability may keep a focus on defense stocks, as countries look to beef up their defense capabilities in a hostile geopolitical environment […]

Stock Analysts

Everest Re Stays Outperform

We are reiterating our Outperform recommendation on the shares of Everest Re Group Ltd. ( RE ), following the solid second quarter earnings results, which included a 20% positive earnings surprise. […]

Stock Analysts

Apache, Sinopec in Global JV

Leading independent energy company, Apache Corp. ( APA ) has entered into a Joint Venture (JV) deal with Sinopec International Petroleum Exploration and Production Corporation, a wholly owned affiliate of China Petrochemical Corporation (Sinopec Group). Per the agreement, Apache will divest 33% interest in its Egypt-based oil and gas business for a total cash consideration of roughly $3.1 billion […]

Stock Analysts

Cincinnati Financial Downgraded to Neutral

On Aug 30, we downgraded our recommendation on the shares of Cincinnati Financial Corp. ( CINF ) to Neutral from Outperform. Though the company posted better than expected second quarter earnings, its greater than average exposure to catastrophes, weak personal lines business and a low interest rate environment keeps us on the sidelines. […]

Stock Analysts

Walgreens Collaborates with Orlando Health

Walgreens ( WAG ) and Florida-based Orlando Health, a not for-profit-healthcare organization, signed a clinical collaboration that will provide integrated and expanded health care services to patients throughout Central Florida, with an added focus on convenience and affordability. The collaboration will see Healthcare Clinics operating at conveniently-located Walgreens during evenings and weekends, with online appointment-scheduling facilities. Orlando Health patients will receive coordinated Healthcare Clinic facilities for chronic and preventive disorders. […]